Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

521 - 530 of 2603 results found

Dual action of epigallocatechin-3-gallate in virus-induced cell Injury

Date
Monday, November 27, 2023 - 4:00 AM
Description
CONCLUSIONS: The EGCG has proven to be an efficient antiviral against SARS-CoV-2 and HSV-2, as well as a wound-healing phytochemical. We assume that EGCG may be a promising option for slowing the course of acute cellular damage induced by systemic